Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-Earnings drive big swings in European stocks ahead of Fed

Wed, 29th Jul 2020 09:50

(For a live blog on European stocks, type LIVE/ in an Eikon
news window)

* Investors await Fed, U.S. fiscal stimulus update

* Paris outperforms as Kering, Schneider earnings support

* Chemicals giant BASF slides as dividend under review
(Updates to market close)

By Sruthi Shankar

July 29 (Reuters) - Europe's main stocks benchmark closed
nearly flat on Wednesday, as investors waited to hear from the
U.S. Federal Reserve, but a flurry of earnings reports drove big
swings in individual stocks.

When the Fed concludes its monetary policy meeting later in
the day, investors are hoping that policymakers will reiterate
their accommodative stance to support financial markets as the
coronavirus pandemic takes its toll.

In a busy earnings day, the pan-European STOXX 600
closed down 0.1%, with healthcare and banks
dragging on the main index, while retailers jumped 1.4%.

Drugmaker GlaxoSmithKline fell 3.2% as it missed
second-quarter profit estimates after lower sales of its
existing vaccines, while lender Barclays dropped 6.1%
as it set aside a higher than expected 1.6 billion pounds ($2.1
billion) to cover a possible rise in loan losses due to the
pandemic.

The pair helped keep London's FTSE 100 nearly flat.

France's CAC 40 outperformed its continental peers
with a 0.6% rise after positive earnings updates from luxury
group Kering, electrical equipment group Schneider
Electric and consulting firm Capgemini.

"Markets have rallied aggressively, so what we're seeing is
companies coming with better numbers but not seeing an
additional uptick in markets," said Will James, deputy head of
European equities at Aberdeen Standard Investments.

"Companies that have managed earnings and sales, there have
been aggressive cost measures put in place."

Profits for STOXX 600 companies are expected to drop by a
record 59% in the second quarter, according to Refinitiv data.
But with much of the decline priced in, European stocks are on
course to end July with gains as investors bet on more stimulus.

Euro zone banks took a beating as Deutsche Bank
fell 2.5% after giving a slightly improved outlook
for the year, but chief executive Christian Sewing damped
speculation that the lender was eager to revive merger talks
with Commerzbank.

Spain's Santander slid 4.7% as it reported a record
net loss of 11.1 billion euros ($13 billion) in the second
quarter.

Chemicals giant BASF SE dropped 4.9% as it said
its dividend policy and the value of assets on its balance sheet
might be revised given uncertainty caused by the coronavirus
crisis.

UK retailer Next jumped 7.7% as it raised its profit
forecast after sales fell less than feared over the past three
months.
(Reporting by Sruthi Shankar in Bengaluru; Editing by Bernard
Orr and Uttaresh.V)

More News
12 Feb 2024 08:35

TOP NEWS: GSK's bepirovirsen receives US FDA fast track designation

(Alliance News) - GSK PLC on Monday said that the US health watchdog granted fast track designation for its bepirovirsen treatment for chronic hepatitis B.

Read more
12 Feb 2024 07:50

LONDON BRIEFING: Tritax Big Box, UK Commercial Property agree merger

(Alliance News) - Equities in London are called to open higher on Monday, with inflation readings from the US and UK on the horizon, which could drive equity market sentiment during the remainder of the week.

Read more
12 Feb 2024 07:21

GSK gets FDA fast track for chronic hepatitis B treatment

(Sharecast News) - GSK announced on Monday that bepirovirsen, an investigational antisense oligonucleotide (ASO) aimed at treating chronic hepatitis B (CHB), had been granted fast track designation by the US Food and Drug Administration (FDA).

Read more
9 Feb 2024 09:15

LONDON BROKER RATINGS: Deutsche Bank cuts AstraZeneca to 'sell'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
6 Feb 2024 08:51

TOP NEWS: GSK reports positive news on trio of high profile products

(Alliance News) - GSK PLC on Tuesday delivered a triple dose of positive updates on some of its leading products, Arexvy, Shingrix and Blencep.

Read more
6 Feb 2024 07:47

LONDON BRIEFING: BP promises buyback despite drop in profit

(Alliance News) - Stocks in London are called to open higher, ahead of a slew of construction purchasing managers' index readings from the eurozone, the UK and Germany.

Read more
6 Feb 2024 07:23

GSK reports positive myeloma trial results, progresses vaccine applications

(Sharecast News) - GSK reported progress in its trial of a myeloma treatment on Tuesday, as well as regulatory progress around its shingles vaccine in China and its RSV vaccine in the United States.

Read more
1 Feb 2024 09:27

TOP NEWS: GSK maintains "vigorous" defence after settling Zantac case

(Alliance News) - GSK PLC on Thursday insisted upon its scientific integrity, after reaching another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
1 Feb 2024 09:11

GSK settles Zantac case in California without admitting liability

(Sharecast News) - GSK announced on Thursday that it had reached a confidential settlement to effectively resolve the legal case over Zantac filed in a California state court.

Read more
1 Feb 2024 09:03

LONDON BROKER RATINGS: Barclays cuts Next; JPMorgan raises easyJet

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
1 Feb 2024 07:42

LONDON BRIEFING: Shell profit falls; announces USD3.5 billion buyback

(Alliance News) - Stocks in London are set to follow New York into the red, after the US Federal Reserve quashed hopes of a March cut to interest rates and ahead of the Bank of England interest rate decision.

Read more
31 Jan 2024 17:05

LONDON MARKET CLOSE: Stocks mixed hours before expected US Fed hold

(Alliance News) - Stock prices in London closed mixed on Wednesday in a trade-thinned day ahead of the US Federal Reserve interest rate decision this evening.

Read more
31 Jan 2024 15:49

London close: Stocks mixed ahead of US Fed, BoE decisions

(Sharecast News) - London's financial markets finished with mixed performance on Wednesday, with investors closing their wallets ahead of rate announcements from both the US Federal Reserve and the Bank of England.

Read more
31 Jan 2024 12:05

LONDON MARKET MIDDAY: FTSE 100 flat ahead of Federal Reserve decision

(Alliance News) - The FTSE 100 in London was flat heading into Wednesday afternoon, as the US Federal Reserve's latest interest rate decision edges closer, keeping equity market enthusiasm to a minimum.

Read more
31 Jan 2024 09:13

TOP NEWS: GSK profit up on Arexvy boost in 2023 but total payout down

(Alliance News) - GSK PLC reported an increase in profit and revenue for 2023 as revenue for HIV medicine had stable growth, amid optimism in the company's outlook.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.